Quality of life as a predictor of one year survival among patients with implantable cardioverter defibrillators

2.50
Hdl Handle:
http://hdl.handle.net/10755/152363
Type:
Presentation
Title:
Quality of life as a predictor of one year survival among patients with implantable cardioverter defibrillators
Abstract:
Quality of life as a predictor of one year survival among patients with implantable cardioverter defibrillators
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Kao, Chi-Wen, PhD, RN
P.I. Institution Name:National Defense Medical Center, Taiwan
Title:Assistant Professor
Co-Authors:Sue A. Thomas, PhD, RN, FAAN and Erika Friedmann, PhD
[Research Presentation] PURPOSE: This study aimed to examine the predictors of one year survival, and to determine the relationship between quality of life (QOL) and one year survival in patients with ICDs. METHOD: The study used the dataset from the Antiarrhythmic Versus Implanted Defibrillator (AVID) controlled clinical trial conducted by the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The 507 patients randomly assigned to the ICD treatment were recruited in the analysis. The subjects were most male (78.3%), with mean age of 64.85¦10.81 years, and mean ejection fraction (EF) of 32.2 +/- 13.45%. The QOL was measured by SF-36 at baseline, 3 months, 6 months, and 1 year follow-up and by Quality of Life Index-Cardiac Version (QLI-CV) at baseline and 1 year follow-up. The depression was evaluated by Mental Health Inventory-5 Items (MHI-5). Data were analyzed by descriptive statistics and logistic regression. RESULTS: The mean of total survival time for the ICD patients was 2.61 +/- 1.24 years. A total of 54 patients died in the first year after ICD implantation, and 445 patients were survival one year after implantation. Four of the predictor variables were significant independent predictors of surviving more than one year after ICD implantation: receiving ACEI therapy (OR= 3.01; 95% Confidence Interval (CI), 1.275, 11.33), age (OR= 1.572; 95% CI, 1.03, 2.398), stress perception at baseline (OR= 1.289; 95% CI, 1.046, 1.589), and QLI-CV (OR= .314; 95% CI, .131,.753). Beyond the effect of bio-psycho-social factors, better QOL predicted more than one year survival [X2 (3, N= 299)= 8.392, p= .039]. The QLI-CV was a significant independent predictor of likelihood of surviving one year after ICD implantation (OR= .314; 95% CI, .131, .753). CONCLUSION: Quality of life is an important factor predicting one year survival in patients with ICDs.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleQuality of life as a predictor of one year survival among patients with implantable cardioverter defibrillatorsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/152363-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Quality of life as a predictor of one year survival among patients with implantable cardioverter defibrillators</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Kao, Chi-Wen, PhD, RN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">National Defense Medical Center, Taiwan</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">chiwenkao@ndmctsgh.edu.tw</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Sue A. Thomas, PhD, RN, FAAN and Erika Friedmann, PhD</td></tr><tr><td colspan="2" class="item-abstract">[Research Presentation] PURPOSE: This study aimed to examine the predictors of one year survival, and to determine the relationship between quality of life (QOL) and one year survival in patients with ICDs. METHOD: The study used the dataset from the Antiarrhythmic Versus Implanted Defibrillator (AVID) controlled clinical trial conducted by the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute. The 507 patients randomly assigned to the ICD treatment were recruited in the analysis. The subjects were most male (78.3%), with mean age of 64.85&brvbar;10.81 years, and mean ejection fraction (EF) of 32.2 +/- 13.45%. The QOL was measured by SF-36 at baseline, 3 months, 6 months, and 1 year follow-up and by Quality of Life Index-Cardiac Version (QLI-CV) at baseline and 1 year follow-up. The depression was evaluated by Mental Health Inventory-5 Items (MHI-5). Data were analyzed by descriptive statistics and logistic regression. RESULTS: The mean of total survival time for the ICD patients was 2.61 +/- 1.24 years. A total of 54 patients died in the first year after ICD implantation, and 445 patients were survival one year after implantation. Four of the predictor variables were significant independent predictors of surviving more than one year after ICD implantation: receiving ACEI therapy (OR= 3.01; 95% Confidence Interval (CI), 1.275, 11.33), age (OR= 1.572; 95% CI, 1.03, 2.398), stress perception at baseline (OR= 1.289; 95% CI, 1.046, 1.589), and QLI-CV (OR= .314; 95% CI, .131,.753). Beyond the effect of bio-psycho-social factors, better QOL predicted more than one year survival [X2 (3, N= 299)= 8.392, p= .039]. The QLI-CV was a significant independent predictor of likelihood of surviving one year after ICD implantation (OR= .314; 95% CI, .131, .753). CONCLUSION: Quality of life is an important factor predicting one year survival in patients with ICDs.</td></tr></table>en_GB
dc.date.available2011-10-26T11:33:29Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T11:33:29Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.